Yearly Archives: 2026

UKC Tuzla Establishes Continuous Endovascular Procedures for the Peripheral Arterial System

The University Clinical Center Tuzla (UKC Tuzla) continues to advance modern treatment methods in the field of invasive cardiology by establishing the continuous performance of endovascular procedures for the treatment of the peripheral arterial system. Percutaneous Transluminal Angioplasty (PTA) is a minimally invasive endovascular procedure used to mechanically dilate a narrowed or occluded artery with…

Over 200 Port Catheters Successfully Implanted at the Clinic for Thoracic Surgery, University Clinical Center Tuzla

During the past year, more than 200 procedures for the implantation of port catheters were successfully performed at the Clinic for Thoracic Surgery of the University Clinical Center Tuzla. The introduction of this procedure began last year following the specialized training of the Clinic’s healthcare staff, conducted under the mentorship of Prof. Dr. Ercan Kocakoc,…

UKC Tuzla Physicians Participate in International HFpEF Workshop in Florence

Physicians from the University Clinical Center Tuzla (UKC Tuzla) took part in the international workshop “Grey Zones in HFpEF Prevention and Diagnosis,” held in Florence and organized by leading international experts in the field of heart failure. The meeting brought together prominent clinicians and researchers from Europe, the United States, Canada, and Japan, focusing on…

UKC Tuzla Successfully Performs Second Kidney Transplant of the Year

The multidisciplinary transplant team at the University Clinical Center Tuzla (UKC Tuzla) has successfully performed its second living- related kidney transplant of the year, in which a mother donated a kidney to her daughter. Head of the Clinic of Urology, Assoc. Prof. Dr. Samed Jagodić, expressed full satisfaction with the outcome of the procedure. “Today,…

Seven Medicines Currently Unavailable at the University Clinical Center Tuzla: Drug Shortages Are a Regional and Global Challenge

At the University Clinical Center Tuzla (UKC Tuzla), treatment modalities, including chemotherapy, are determined individually for each patient. Decisions are made through a multidisciplinary consultation, after which the proposed therapy is submitted for approval to the Committee of the Federal Institute of Health Insurance and Reinsurance. Once the Committee approves the requested therapy, the patient’s…